Our lab has developed an ML-enabled 3D live cell sensitivity and resistance assay that overcomes limitations of previous live cell assays.

The SAGE Direct Test™ helps you identify the most effective therapy – independent of your patient’s tumor mutational status. We make it easy for you to go the extra mile – beyond Standard of Care.

If Standard of Care has failed your patient, we can examine your patient’s fresh tissue biopsy and provide you with our SAGE Direct Test™ report in 1 week.

Learn more about the program

If your patient has a resectable tumor, please join our tissue donation program in collaboration with the National Foundation of Cancer Research (NFCR). 

Learn more about the program